Annual FCF:
-$40.69M-$17.31M(-74.02%)Summary
- As of today, AKBA annual free cash flow is -$40.69 million, with the most recent change of -$17.31 million (-74.02%) on December 31, 2024.
- During the last 3 years, AKBA annual free cash flow has risen by +$212.33 million (+83.92%).
- AKBA annual free cash flow is now -173.66% below its all-time high of $55.24 million, reached on December 31, 2016.
Performance
AKBA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$22.22M+$35.82M(+263.31%)Summary
- As of today, AKBA quarterly free cash flow is $22.22 million, with the most recent change of +$35.82 million (+263.31%) on June 1, 2025.
- Over the past year, AKBA quarterly free cash flow has increased by +$32.31 million (+320.10%).
- AKBA quarterly free cash flow is now -76.76% below its all-time high of $95.62 million, reached on December 31, 2016.
Performance
AKBA Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$2.55M+$32.31M(+92.68%)Summary
- As of today, AKBA TTM free cash flow is -$2.55 million, with the most recent change of +$32.31 million (+92.68%) on June 1, 2025.
- Over the past year, AKBA TTM free cash flow has increased by +$36.45 million (+93.46%).
- AKBA TTM free cash flow is now -103.17% below its all-time high of $80.38 million, reached on June 30, 2017.
Performance
AKBA TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AKBA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -74.0% | +320.1% | +93.5% |
| 3Y3 Years | +83.9% | +172.5% | +98.5% |
| 5Y5 Years | +84.6% | -40.2% | +98.5% |
AKBA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -74.0% | +83.9% | -34.3% | +140.6% | at high | +96.9% |
| 5Y | 5-Year | -74.0% | +84.6% | -34.3% | +131.4% | at high | +99.0% |
| All-Time | All-Time | -173.7% | +84.6% | -76.8% | +115.9% | -103.2% | +99.0% |
AKBA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $22.22M(+263.3%) | -$2.55M(+92.7%) |
| Mar 2025 | - | -$13.61M(-204.5%) | -$34.87M(+14.3%) |
| Dec 2024 | -$40.69M(-74.0%) | -$4.47M(+33.3%) | -$40.69M(-5.6%) |
| Sep 2024 | - | -$6.70M(+33.7%) | -$38.53M(+1.2%) |
| Jun 2024 | - | -$10.10M(+48.0%) | -$39.00M(-54.3%) |
| Mar 2024 | - | -$19.43M(-741.9%) | -$25.28M(-8.1%) |
| Dec 2023 | -$23.38M(+68.1%) | -$2.31M(+67.8%) | -$23.38M(+69.1%) |
| Sep 2023 | - | -$7.17M(-297.5%) | -$75.75M(-117.8%) |
| Jun 2023 | - | $3.63M(+120.7%) | -$34.78M(+49.6%) |
| Mar 2023 | - | -$17.54M(+67.9%) | -$69.07M(+5.7%) |
| Dec 2022 | -$73.27M(+71.0%) | -$54.68M(-261.7%) | -$73.27M(+10.0%) |
| Sep 2022 | - | $33.80M(+210.3%) | -$81.40M(+52.5%) |
| Jun 2022 | - | -$30.66M(-41.1%) | -$171.47M(+15.9%) |
| Mar 2022 | - | -$21.73M(+65.4%) | -$203.95M(+19.4%) |
| Dec 2021 | -$253.02M(-128.6%) | -$62.81M(-11.6%) | -$253.02M(-14.3%) |
| Sep 2021 | - | -$56.27M(+10.9%) | -$221.31M(-15.1%) |
| Jun 2021 | - | -$63.14M(+10.8%) | -$192.24M(-109.1%) |
| Mar 2021 | - | -$70.81M(-127.7%) | -$91.92M(+17.0%) |
| Dec 2020 | -$110.70M(+58.1%) | -$31.10M(-14.4%) | -$110.70M(+35.6%) |
| Sep 2020 | - | -$27.19M(-173.1%) | -$171.96M(-26.2%) |
| Jun 2020 | - | $37.17M(+141.5%) | -$136.31M(+36.3%) |
| Mar 2020 | - | -$89.59M(+3.0%) | -$213.83M(+19.0%) |
| Dec 2019 | -$264.10M(-166.5%) | -$92.36M(-1191.7%) | -$264.10M(-7.2%) |
| Sep 2019 | - | $8.46M(+121.0%) | -$246.27M(+7.9%) |
| Jun 2019 | - | -$40.34M(+71.2%) | -$267.50M(-22.5%) |
| Mar 2019 | - | -$139.86M(-87.7%) | -$218.33M(-120.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$99.10M(-71.5%) | -$74.53M(-483.7%) | -$99.10M(-139.4%) |
| Sep 2018 | - | -$12.77M(-244.7%) | -$41.40M(+50.6%) |
| Jun 2018 | - | $8.82M(+142.8%) | -$83.84M(-22.5%) |
| Mar 2018 | - | -$20.63M(-22.6%) | -$68.45M(-18.5%) |
| Dec 2017 | -$57.78M(-204.6%) | -$16.83M(+69.5%) | -$57.78M(-205.7%) |
| Sep 2017 | - | -$55.21M(-328.0%) | $54.67M(-32.0%) |
| Jun 2017 | - | $24.22M(+343.3%) | $80.38M(+187.5%) |
| Mar 2017 | - | -$9.96M(-110.4%) | $27.96M(-49.4%) |
| Dec 2016 | $55.24M(+204.6%) | $95.62M(+424.2%) | $55.24M(+187.2%) |
| Sep 2016 | - | -$29.50M(-4.6%) | -$63.36M(-47.3%) |
| Jun 2016 | - | -$28.20M(-262.8%) | -$43.01M(-59.6%) |
| Mar 2016 | - | $17.32M(+175.4%) | -$26.95M(+49.0%) |
| Dec 2015 | -$52.82M(-90.6%) | -$22.98M(-151.3%) | -$52.82M(-35.2%) |
| Sep 2015 | - | -$9.15M(+24.7%) | -$39.06M(-9.9%) |
| Jun 2015 | - | -$12.14M(-42.1%) | -$35.56M(-18.1%) |
| Mar 2015 | - | -$8.55M(+7.3%) | -$30.11M(-8.7%) |
| Dec 2014 | -$27.71M(-144.1%) | -$9.22M(-63.5%) | -$27.71M(-18.4%) |
| Sep 2014 | - | -$5.64M(+15.8%) | -$23.41M(-13.0%) |
| Jun 2014 | - | -$6.70M(-8.9%) | -$20.71M(-29.7%) |
| Mar 2014 | - | -$6.15M(-25.0%) | -$15.97M(-40.7%) |
| Dec 2013 | -$11.35M(-57.4%) | -$4.92M(-67.2%) | -$11.35M(-76.5%) |
| Sep 2013 | - | -$2.94M(-50.4%) | -$6.43M(-84.4%) |
| Jun 2013 | - | -$1.96M(-27.9%) | -$3.49M(-127.9%) |
| Mar 2013 | - | -$1.53M | -$1.53M |
| Dec 2012 | -$7.21M(+49.2%) | - | - |
| Dec 2011 | -$14.18M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Akebia Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Akebia Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of AKBA is -$40.69M
What is the all-time high annual free cash flow for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual free cash flow is $55.24M
What is Akebia Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, AKBA annual free cash flow has changed by -$17.31M (-74.02%)
What is Akebia Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of AKBA is $22.22M
What is the all-time high quarterly free cash flow for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly free cash flow is $95.62M
What is Akebia Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, AKBA quarterly free cash flow has changed by +$32.31M (+320.10%)
What is Akebia Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of AKBA is -$2.55M
What is the all-time high TTM free cash flow for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM free cash flow is $80.38M
What is Akebia Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, AKBA TTM free cash flow has changed by +$36.45M (+93.46%)